Parabolic Drugs Executive and Leadership Team

Ashok Jindal, the Chief Financial Officer at Parabolic Drugs, manages the fiscal health and capital allocation strategies for the entire manufacturing enterprise. Overseeing financial reporting, risk management, and budgetary planning, the Chief Financial Officer ensures the company maintains robust liquidity to support large-scale R&D investments. Jindal directs the integration of cost-control measures across the four primary production facilities to maximize operational efficiency. By aligning fiscal policy with the long-term goals of the board, the Chief Financial Officer secures the necessary funding for patent development and infrastructure expansion. Ashok Jindal monitors global market trends to optimize pricing strategies for active pharmaceutical ingredients. This leadership role involves maintaining strict compliance with international financial regulations while driving sustainable growth. Through precise financial oversight, the Chief Financial Officer strengthens the market position of the organization within the competitive pharmaceutical landscape, ensuring consistent value creation for all stakeholders involved in the business.

Ajeet Nigam, the Global President, Api Marketing at Parabolic Drugs, directs the international sales strategy and market expansion for the company's extensive portfolio of active pharmaceutical ingredients. Overseeing the commercial relationships with global partners, the Global President, Api Marketing ensures that the organization meets the specific needs of diverse therapeutic segments. Nigam architects the outreach programs that promote the company's custom synthesis capabilities to international pharmaceutical manufacturers. By analyzing regional market demands, the Global President, Api Marketing optimizes the distribution network to ensure timely delivery of high-quality intermediates. Ajeet Nigam collaborates with the R&D team to align product development with emerging global health trends. This leadership role involves managing complex supply chain logistics to maintain a competitive edge in the global pharmaceutical industry. Through strategic market positioning and client engagement, the Global President, Api Marketing drives revenue growth and expands the footprint of the company across key international territories.

Yatish Bansal, the President, Technical at Parabolic Drugs, oversees the engineering, manufacturing, and research infrastructure across all four production facilities. Directing the technical teams, the President, Technical ensures that the synthesis of active pharmaceutical ingredients meets the highest standards of purity and efficacy. Bansal architects the implementation of state-of-the-art manufacturing technologies to enhance production capacity and process innovation. By managing the R&D center, the President, Technical drives the development of novel processes and the filing of new patents. Yatish Bansal coordinates with the quality assurance departments to maintain compliance with international manufacturing standards. This leadership role involves optimizing the technical workflows to reduce waste and improve yield across the entire product portfolio. Through the application of advanced scientific expertise, the President, Technical supports the company's commitment to delivering high-quality pharmaceutical solutions, ensuring that the technical infrastructure remains at the forefront of the industry while supporting the broader goals of the organization.

Vineet Gupta, the Whole Time Director at Parabolic Drugs, governs the strategic direction and corporate compliance of the pharmaceutical manufacturing operations. Overseeing the alignment between the board of directors and daily business activities, the Whole Time Director ensures that all manufacturing plants adhere to rigorous quality standards and regulatory requirements. Gupta architects the organizational framework that supports the production of over 50 active pharmaceutical ingredients. By coordinating cross-departmental initiatives, the Whole Time Director facilitates seamless communication between the R&D center and the commercial divisions. Vineet Gupta monitors the execution of corporate policies to maintain the integrity of the intellectual property portfolio, including Drug Master Files. This leadership role involves evaluating long-term business risks and identifying opportunities for vertical integration. Through consistent oversight of operational performance, the Whole Time Director drives the company toward achieving its mission of delivering high-quality pharmaceutical products to international markets while maintaining excellence in corporate governance.